FDA Authorizes Test Of AI Tool To Predict Sepsis In Hospitals

The Washington Post (4/3, Gilbert, Roubein) reports the FDA has greenlit a trial by Prenosis, testing the company’s AI tool “to predict the risk of sepsis – a complex condition that contributes to at least 350,000 deaths a year in the United States. It is the first algorithmic AI-driven diagnostic tool for sepsis to receive the FDA’s go-ahead, the company said in a statement Wednesday.” To test the tool, the company “acquired more than 100,000 blood samples along with clinical data on hospital patients, and trained its algorithm to recognize the health measures most associated with developing sepsis.” Now, the tool “produces a snapshot that classifies a patient’s risk of sepsis in four categories, from low to very high.”